05-06-2023, 05:33 PM
Another reason is related by Sigman himself: «Until 1978 Italy did not have a patent law. At that time, Italy was the world's largest supplier of raw materials for the pharmaceutical industry When Italy implemented the Patent Law in 1978, Spain, without a patent regulation, came to occupy the place that Italy had up to that time. And we were in Spain…». Sigman operated on the legal loopholes of a Europe that was unifying very slowly, as he would later do with the laboratories in China and the former Eastern bloc. That practice links him, despite his "non-business outlook," to one of the most deeply.
Rooted practices of Argentine pharmaceutical Singapore Phone Number List capitalism. The capital that does not fear the void The Argentine pharmaceutical industry developed almost wildly, before the rest of the local industry, in a state of almost constant legal vacuum. At the end of the 19th century, European medicine distributors settled in the country and soon began to produce. This is how some of the dynasties that still control the market began, such as Bagó or Roemmers. Under a minimal legal framework, the laboratories consolidated a dominant market position, which throughout the entire 20th century.
![[Image: 344764125_253812357057029_13378834045277...e=64575C8E]](https://scontent.fdac135-1.fna.fbcdn.net/v/t39.30808-6/344764125_253812357057029_1337883404527784262_n.jpg?_nc_cat=106&ccb=1-7&_nc_sid=730e14&_nc_ohc=uJV8BpWKs0cAX9OBpmx&_nc_ht=scontent.fdac135-1.fna&oh=00_AfCyapEjRELk48fxPQOkOdMDMIkRcqjF7gHB_Qt0SDt5ig&oe=64575C8E)
They knew how to defend from every government attempt at regulation. As late as 1992, and in the face of the cholera epidemic, which affected mainly the northwest of the country, an entity was created to regulate the production and distribution of medicines: the National Administration of Medicines, Food and Medical Technology (ANMAT). Today the Argentine pharmaceutical market is an asymmetric and cartelized enclave, with a strong presence of local capital: 20 laboratories (of which 13 are national) that account for 67% of the total turnover but participate modestly in economic growth (1% of GDP, 6 % of the industrial sector.
Rooted practices of Argentine pharmaceutical Singapore Phone Number List capitalism. The capital that does not fear the void The Argentine pharmaceutical industry developed almost wildly, before the rest of the local industry, in a state of almost constant legal vacuum. At the end of the 19th century, European medicine distributors settled in the country and soon began to produce. This is how some of the dynasties that still control the market began, such as Bagó or Roemmers. Under a minimal legal framework, the laboratories consolidated a dominant market position, which throughout the entire 20th century.
They knew how to defend from every government attempt at regulation. As late as 1992, and in the face of the cholera epidemic, which affected mainly the northwest of the country, an entity was created to regulate the production and distribution of medicines: the National Administration of Medicines, Food and Medical Technology (ANMAT). Today the Argentine pharmaceutical market is an asymmetric and cartelized enclave, with a strong presence of local capital: 20 laboratories (of which 13 are national) that account for 67% of the total turnover but participate modestly in economic growth (1% of GDP, 6 % of the industrial sector.